Efficacy and tolerability of 5% sodium L-ascorbyl-2-phosphate lotion, as maintenance therapy, for moderate to severe acne in comparison with 0.1% adapalene gel

被引:0
|
作者
Ikeno, Hioroshi [1 ]
Kita, Takashi [2 ]
Nishikawa, Takeshi [3 ]
机构
[1] Ikeno Clin Dermatol & Dermatol Surg, Tokyo, Japan
[2] Kita Clin Plast Surg & Esthet Surg, Tokushima, Japan
[3] Hokkaido Univ, Sapporo, Hokkaido, Japan
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:AB16 / AB16
页数:1
相关论文
共 34 条
  • [21] Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial
    Capizzi, R
    Landi, F
    Milani, M
    Amerio, P
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (02) : 481 - 484
  • [22] Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Low Concentration Benzoyl Peroxide (2.5%) Aqueous Gel in Moderate or Severe Acne Subpopulations
    Webster, Guy
    Rich, Phoebe
    Gold, Michael H.
    Mraz, Serena
    Calvarese, Barry
    Chen, Diana
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 736 - 743
  • [23] Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysis
    Callender, Valerie D.
    Baldwin, Hilary
    Gold, Linda Stein
    Cook-Bolden, Fran E.
    Guenin, Eric
    Alexis, Andrew F.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [24] Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials
    Gold, Linda Stein
    Lain, Edward
    Del Rosso, James Q.
    Gold, Michael
    Draelos, Zoe D.
    Eichenfield, Lawrence F.
    Sadick, Neil
    Werschler, William P.
    Gooderham, Melinda J.
    Lupo, Mary
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (05) : 927 - 935
  • [25] Impact of Age or Sex on Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel in Participants with Moderate-to-Severe Acne
    Gold, Linda Stein
    Kircik, Leon
    Werschler, William
    Baldwin, Hilary
    Callender, Valerie
    Green, Lawrence
    Sadick, Neil
    Sugarman, Jeffrey
    Draelos, Zoe
    Tanghetti, Emil
    Bhatia, Neal
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB54 - AB54
  • [26] Treatment of Moderate to Severe Acne Vulgaris in a Hispanic Population: A Post-Hoc Analysis of Efficacy and Tolerability of Clindamycin Phosphate 1.2%/Benzoyl Peroxide 2.5% Gel
    Cook-Bolden, Fran E.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (04) : 455 - 459
  • [27] Evaluation of the efficacy of maintenance therapy for acne vulgaris using adapalene 0.1%/benzoyl peroxide 2.5% gel and benzoyl peroxide 2.5% gel for 24?weeks and assessment of atrophic acne scars using three-dimensional image analysis
    Tanizaki, Hideaki
    Hayashi, Nobukazu
    Abe, Masatoshi
    JOURNAL OF DERMATOLOGY, 2023, 50 (12): : 1513 - 1522
  • [28] Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study
    Eichenfield, Lawrence F.
    Gold, Linda Stein
    Kircik, Leon H.
    Werschler, William P.
    Beer, Kenneth
    Draelos, Zoe D.
    Tanghetti, Emil A.
    Papp, Kim A.
    Baldwin, Hilary
    Lain, Edward
    Sadick, Neil
    Gooderham, Melinda J.
    Konda, Adarsh
    PEDIATRIC DERMATOLOGY, 2023, 40 (03) : 452 - 459
  • [29] Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial
    Nicklas, Claudia
    Rubio, Rocio
    Cardenas, Consuelo
    Hasson, Ariel
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2019, 35 (01) : 3 - 10
  • [30] Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
    Linda Stein Gold
    Hilary Baldwin
    Leon H. Kircik
    Jonathan S. Weiss
    David M. Pariser
    Valerie Callender
    Edward Lain
    Michael Gold
    Kenneth Beer
    Zoe Draelos
    Neil Sadick
    Radhakrishnan Pillai
    Varsha Bhatt
    Emil A. Tanghetti
    American Journal of Clinical Dermatology, 2022, 23 : 93 - 104